MIELOPATIE VASCOLARI. SINDROME DELL' ARTERIA SPINALE ANTERIORE. CONSIDERAZIONI SU QUATTRO CASI = MYELOPATHIES VASCULAIRES. SYNDROME DE L'ARTERE SPECIALE ANTERIEURE. CONSIDERATIONS SUR 4 CASRAMPONI G; MARRA A; MORANDI L et al.1979; MINERVA MED.; ITA; DA. 1979; VOL. 70; NO 8; PP. 611-615; ABS. ENG; BIBL. 15 REF.Article

Repetitive nerve stimulation and muscle membrane excitability: case report and reviewSCAIOLI, V; MORANDI, L.Electromyography and clinical neurophysiology. 2002, Vol 42, Num 6, pp 333-336, issn 0301-150X, 4 p.Article

Low bone density and bone metabolism alterations in Duchenne muscular dystrophy: response to calcium and vitamin D treatmentBIANCHI, M. L; MORANDI, L; ANDREUCCI, E et al.Osteoporosis international. 2011, Vol 22, Num 2, pp 529-539, issn 0937-941X, 11 p.Article

Atypical cutaneous mycobacteriosis diagnosed by polymerase chain reactionCOLLINA, G; MORANDI, L; LANZONI, A et al.British journal of dermatology (1951). 2002, Vol 147, Num 4, pp 781-784, issn 0007-0963, 4 p.Article

X-linked Emery-Dreifuss muscular dystrophy can be diagnosed from skin biopsy or blood sampleMORA, M; CARTEGNI, L; DONATI, M. A et al.Annals of neurology. 1997, Vol 42, Num 2, pp 249-253, issn 0364-5134Article

Identification of new mutations in the Emery-Dreifuss muscular dystrophy gene and evidence for genetic heterogeneity of the diseaseBIONE, S; SMALL, K; TONIOLO, D et al.Human molecular genetics (Print). 1995, Vol 4, Num 10, pp 1859-1863, issn 0964-6906Article

Dystrophin analysis in Duchenne and Becker muscular dystrophy carriers : correlation with intracellular calcium and albuminMORANDI, L; MORA, M; GUSSONI, E et al.Annals of neurology. 1990, Vol 28, Num 5, pp 674-679, issn 0364-5134, 6 p.Article

The neurotrophin receptor p75NTR is induced on mature myofibres in inflammatory myopathies and promotes myotube survival to inflammatory stressCOLOMBO, E; ROMAGGI, S; BLASEVICH, F et al.Neuropathology and applied neurobiology (Print). 2012, Vol 38, Num 4, pp 367-378, issn 0305-1846, 12 p.Article

Clinical correlations in 16 patients with total or partial laminin α2 deficiency characterized using antibodies against 2 fragments of the proteinMORANDI, L; DI BLASI, C; CORNELIO, F et al.Archives of neurology (Chicago). 1999, Vol 56, Num 2, pp 209-215, issn 0003-9942Article

A new non-radioactive method for the screening and prenatal diagnosis of myotonic dystrophy patientsBRUGNONI, R; MORANDI, L; BRAMBATI, B et al.Journal of neurology. 1998, Vol 245, Num 5, pp 289-293, issn 0340-5354Article

Fetus-like dystrophin expression and other cytoskeletal protein abnormalities in centronuclear myopathiesMORA, M; MORANDI, L; CORNELIO, F et al.Muscle & nerve. 1994, Vol 17, Num 10, pp 1176-1184, issn 0148-639XArticle

Content of methylhistidines in normal and pathological human skeletal musclesMUSSINI, E; CORNELIO, F; DWORZAK, F et al.Muscle & nerve. 1983, Vol 6, Num 6, pp 423-429, issn 0148-639XArticle

Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population studyMERCURI, E; MESSINA, S; BOFFI, P et al.Neurology. 2009, Vol 72, Num 21, pp 1802-1809, issn 0028-3878, 8 p.Article

Diagnosis of glycogenosis type IIBEMBI, B; CERINI, E; TOSCANO, A et al.Neurology. 2008, Vol 71, Num 23, issn 0028-3878, S4-S11, SUP2Conference Paper

Partial laminin α2 chain deficiency in a patient with myopathy resembling inclusion body myositisDI BLASI, C; MORA, M; PAREYSON, D et al.Annals of neurology. 2000, Vol 47, Num 6, pp 811-816, issn 0364-5134Article

Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expressionLANFOSSI, M; COZZI, F; BUGINI, D et al.Acta neuropathologica. 1999, Vol 97, Num 2, pp 127-138, issn 0001-6322Article

Congenital muscular dystrophy with merosin deficiency : MRI findings in five patientsFARINA, L; MORANDI, L; MILANESI, I et al.Neuroradiology (Berlin. Print). 1998, Vol 40, Num 12, pp 807-811, issn 0028-3940Article

Concomitant deficiency of β- and γ-sarcoglycans in 20 α-sarcoglycan (adhalin)-deficient patients : immunohistochemical analysis and clinical aspectsBARRESI, R; CONFALONIERI, V; PINI, A et al.Acta neuropathologica. 1997, Vol 94, Num 1, pp 28-35, issn 0001-6322Article

DMD and BMD in the same family due to two distinct mutationsMORANDI, L; MORA, M; CORNELIO, F et al.American journal of medical genetics. 1995, Vol 59, Num 4, pp 501-505, issn 0148-7299Article

Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 yearsANGELINI, C; SEMPLICINI, C; TONIN, P et al.Journal of neurology. 2012, Vol 259, Num 5, pp 952-958, issn 0340-5354, 7 p.Article

Type I interferon and Toll-like receptor expression characterizes inflammatory myopathiesCAPPELLETTI, C; BAGGI, F; MANTEGAZZA, R et al.Neurology. 2011, Vol 76, Num 24, pp 2079-2088, issn 0028-3878, 10 p.Article

Expression of protein kinase C isoforms and interleukin-1β in myofibrillar myopathyVATTEMI, G; TONIN, P; MORA, M et al.Neurology. 2004, Vol 62, Num 10, pp 1778-1782, issn 0028-3878, 5 p.Article

Bone mineral density and bone metabolism in Duchenne muscular dystrophyBIANCHI, M. L; MAZZANTI, A; GALBIATI, E et al.Osteoporosis international. 2003, Vol 14, Num 9, pp 761-767, issn 0937-941X, 7 p.Article

Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutationsBARRESI, R; DI BLASI, C; MORA, M et al.Journal of medical genetics. 2000, Vol 37, Num 2, pp 102-107, issn 0022-2593Article

Clinical heterogeneity of adhalin deficiencyMORANDI, L; BARRESI, R; PINI, A et al.Annals of neurology. 1996, Vol 39, Num 2, pp 196-202, issn 0364-5134Article